NICE issues positive appraisal document for combination treatment for advanced kidney cancer
August 22, 2022Sales and Marketing
NICE has published an appraisal consultation document (ACD) recommending the use of lenvatinib as a therapeutic option for untreated intermediate …
EMA accept marketing authorisation application for invasive candidiasis treatment
August 22, 2022Sales and Marketing
The EMA has accepted the marketing authorisation application (MAA) for rezafungin, for the treatment of invasive candidiasis in adult patients. …
New WHO recommendations for Ebola treatments and improved access
August 22, 2022Sales and Marketing
WHO has published its first guideline for Ebola virus disease therapeutics, calling on the global community to increase access to …
GSK awarded UNICEF contract for malaria vaccine
August 19, 2022Medical Communications
In 2020, nearly half a million children died from malaria in Africa alone, a rate of one child death per …
New COVID-19 study from The Lancet Psychiatry journal shows higher risk of brain fog
August 19, 2022Medical Communications
The study also found that adults faced an increased risk of anxiety and depression, but this subsided within two months …
Home-based brain stimulation study on stroke survivors finds mixed results
August 19, 2022Medical Communications
26 stroke survivors were given four weeks of remotely supervised transcranial direct current stimulation (RS-tDCS) in an at-home cognitive rehabilitation …
Jazz Pharmaceuticals takes groundbreaking epilepsy drug Epidiolex for adolescents into phase III trial
August 19, 2022Medical Communications
The phase III trials will assess Epidiolex over 14 weeks in a randomised, double-blind, placebo-controlled study, enrolling paediatric patients aged …
GSK’s new drug application for momelotinib accepted by FDA
August 18, 2022Business Services
The potential drug treatment is for myelofibrosis patients with anaemia UK-based GSK has announced that the US Food and Drug …
NHS Scotland recommends Chiesi’s Trimbow for asthma
August 18, 2022Business Services
In the UK, 5.4 million people are currently receiving treatment for asthma Chiesi Limited has announced that the Scottish Medicines …
Newly discovered peptide shows promising results in preventing seizures; a potential future treatment for epilepsy and Alzheimer’s
August 18, 2022Business Services
A study published in The American Society for Clinical Investigation highlights developments made by researchers to develop A1R-CT, a peptide …
New method involving musical tests can enable early detection of cognitive decline
August 18, 2022Business Services
Researchers at Tel Aviv University have created a method which uses musical tests and a portable brain activity-measuring device to …
Evonetix commences access programme for synthesised DNA
August 17, 2022Research and Development
Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Evonetix has announced the opening …
Lynparza combination therapy gets FDA priority review for prostate cancer
August 17, 2022Research and Development
Lynparza is being jointly developed by UK-based AstraZeneca and MSD AstraZeneca’s supplemental new drug application for Lynparza (olaparib) in combination …
Successful study to change the blood type of donor kidneys means access for more BAME recipients
August 17, 2022Research and Development
Scientists at the University of Cambridge have successfully altered the blood type of donor kidneys in a study which could …
Patient with HNSCC dosed with triple combination therapy in Phase II of Genexine clinical trial
August 17, 2022Research and Development
Genexine, a South Korean clinical-staged biopharmaceutical company, have announced the dosing with triple combination therapy of the first patient with …
Santen launches Ducressa for post-cataract surgery
August 16, 2022Manufacturing and Production
Treatment involves a combination of levofloxacin and dexamethasone for use after cataract surgery Santen has announced the launch of Ducressa …
The impact of COVID-19 on the fight against AMR
August 16, 2022Manufacturing and Production
How the responses to the COVID-19 pandemic have affected antibiotic-resistant bacteria Responses to the COVID-19 pandemic may have impacted …
BrainStorm’s ALS-combatting drug finally on its way to the FDA
August 16, 2022Manufacturing and Production
BrainStorm Cell Therapeutics’ NurOne was rejected by the Food and Drug Association in February 2021 but this year, after consulting …
UK first country to approve bivalent booster which targets both original COVID-19 as well as the Omicron strain
August 16, 2022Manufacturing and Production
The UK medicines regulator (MHRA) has given the Moderna-made vaccine conditional approval, backed up by the Joint Committee on Vaccination …
Sanofi and NIHR enrol first patient in immunisation study for RSV in infants
August 15, 2022Sales and Marketing
The European study will evaluate the use of the human recombinant monoclonal antibody nirsevimab Sanofi and the National Institute …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
